Cargando…
An insight on promising strategies hoping to cure HIV-1 infection by targeting Rev protein—short review
Human immunodeficiency virus-1 (HIV-1) infection remains to be one of the major threats throughout the world. Many researchers are working in this area to find a cure for HIV-1. The group of the FDA approved drugs which are currently used against HIV-1 in the clinical practice include nucleoside rev...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460518/ https://www.ncbi.nlm.nih.gov/pubmed/33840054 http://dx.doi.org/10.1007/s43440-021-00257-9 |